Navigation Links
Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Date:5/15/2013

stigational compounds in our growing oncology pipeline."

The LUX-Lung 6 Clinical Trial of Afatinib
LUX-Lung 6 (Efficacy) Abstract: #8016
Poster Discussion: Sunday, June 2, 11:30 AM-12:30 PM, poster board #5

The LUX-Lung 6 trial is the largest randomized, open-label Phase III trial conducted to date in the EGFR mutation-positive advanced (stage IIIb or IV) NSCLC patient population. The trial evaluated afatinib compared to standard chemotherapy (gemcitabine and cisplatin), as a first-line treatment in 364 Asian patients.1

The trial met its primary endpoint of PFS as assessed by independent central review; within the general study population, patients treated with afatinib (n=242) lived for a median of 11.0 months before their tumor started to grow again versus 5.6 months for patients treated with chemotherapy (n=122) (HR=0.28, p<0.0001).1 The PFS findings were consistent across EGFR mutation sub-groups.1 Secondary efficacy endpoints included objective response rate (ORR: proportion of patients with tumor size reduction of a predefined amount and for a minimum time period3) and disease control rate (DCR: proportion of patients who have achieved complete response, partial response and stable disease4). Patients treated with afatinib experienced significantly higher ORR (66.9% versus 23.0%, p<0.0001) and DCR (92.6% versus 76.2%, p<0.0001) compared to patients treated with chemotherapy.1

The most common greater than or equal to grade 3 drug-related adverse events observed in the afatinib treatment arm were rash/acne (14.6%), diarrhea (5.4%) and stomatitis/mucositis (5.4%).1 The most common greater than or equal to grade 3 drug-related adverse events observed in the gemcitabine/cisplatin treatment arm were neutropenia (17.7%), vomiting (15.9%) and leukopenia (13.3%).1 Overall, 5.9 percent of patients treated
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7, 2015  Air Products (NYSE: APD ) will ... systems—including high efficiency systems that reduce oxygen loss and systems ... Conference and Technical Exhibition in Boston, Mass. ... invited to stop by Air Products booth 913 to learn ... as much as 30 percent, change out their gas storage ...
(Date:7/7/2015)... 7, 2015 C,est ... annonce l,acquisition de 20% du Groupe TRB, ... spécialisée dans la fabrication de médicaments et ...      (Logo: http://photos.prnewswire.com/prnh/20150707/232398LOGO) , ... groupes chimiques et pharmaceutiques italiens, qui contrôle, ...
(Date:7/7/2015)... -- The Arentz Law Group is currently investigating cases of birth ... who have taken Zyban while pregnant, and given birth to ... contact the law firm immediately for a free legal ... American Journal of Obstetrics & Gynecology  showed that mothers ... giving birth to a child with " left outflow tract ...
Breaking Medicine Technology:Air Products Highlights Reliability and Efficiency of Its Medical Oxygen Supply Systems at ASHE Conference and Exhibition 2Smoking cessation drug linked to birth defects when taken during pregnancy 2
... The Motorola Solutions business of Motorola, Inc. ... mobile computing solution for healthcare ... The new MC75A0-HC provides healthcare organizations with a rugged ... and safety, streamline and error-proof processes, and support a ...
... DALLAS and NEW YORK, Sept. 15 ACCESS ... ), a biopharmaceutical company specializing in products for cancer ... www.MuGard.com .  The patient- and healthcare professional- focused site ... mucositis, patient analysis, MuGard product and how-to-order information. ...
Cached Medicine Technology:Motorola Advances Healthcare Mobility With New Enterprise Digital Assistant 2Motorola Advances Healthcare Mobility With New Enterprise Digital Assistant 3Motorola Advances Healthcare Mobility With New Enterprise Digital Assistant 4Motorola Advances Healthcare Mobility With New Enterprise Digital Assistant 5Access Pharmaceuticals Launches MuGard Product Website 2Access Pharmaceuticals Launches MuGard Product Website 3
(Date:7/7/2015)... Aspen, CO (PRWEB) , ... July 07, 2015 ... ... 726 skin cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible ... These potential diagnoses must be confirmed with additional testing. , The Aspen Ideas ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... Times highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. ... U.S. Secretary of State looks more youthful than she has in some time ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the ... and CelestixFederated VA Series virtual appliances. These virtual platforms expand the existing ... which have proven to simplify the on-premises deployment of unified remote access and ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health ... Excelimmune, Inc. to access its antibody combination therapy (ACT) technology platform. The ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... experience for its patient community using its IDF ePHR, an electronic personal health ... immunodeficiency diseases (PI) to easily track their health information, including symptoms, diagnoses, medications, ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... , FRIDAY, Nov. 5 (HealthDay News) -- People undergoing cancer ... possible and avoid exertion, to save all their strength to ... physicians and researchers now say that people who remain physically ... to beat cancer. The positive evidence for exercise during ...
... , FRIDAY, Nov. 5 (HealthDay News) -- Falls from tree ... an Ohio State University study. Researchers analyzed 130 hunting-related ... found that 50 percent of injuries were caused by falls, ... Among the other findings: , Gunshot wounds accounted ...
... , FRIDAY, Nov. 5 (HealthDay News) -- Over ... inflammatory kidney disorder known as lupus nephritis have vastly improved, ... with lupus nephritis, which is a complication that can occur ... can now expect a better quality of life, without many ...
... sent to physicians the moment they ordered a blood ... that is often false-positive for the elderly, according to a ... of Managed Care . The D-dimer test, combined ... of deep vein thrombosis (blood clots in veins, otherwise known ...
... Nov. 5 (HealthDay News) -- New genetic mapping of ... a particular gene mutation are particularly well-skilled in the ... between a specific variation of the so-called "PCSK6 gene" ... hard evidence to suggest that there could be an ...
... DC A large national study finds that screening current ... deaths from lung cancers by 20 percent. One potential ... up tumors at an early stage. The study was ... the country including Georgetown Lombardi Comprehensive Cancer Center, a part ...
Cached Medicine News:Health News:To Best Fight Cancer, New Guidelines Urge Exercise 2Health News:To Best Fight Cancer, New Guidelines Urge Exercise 3Health News:To Best Fight Cancer, New Guidelines Urge Exercise 4Health News:Lupus Kidney Disorder Treatment Improved Over Decade: Review 2Health News:Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients 2Health News:Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients 3Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2Health News:National study shows CT screening of former, current smokers reduces lung cancer deaths 2Health News:National study shows CT screening of former, current smokers reduces lung cancer deaths 3
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
250L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: